Oncology News International April 2009 Vol. 18 No. 4

Publication
Article

Cover Story

Optimal use of aromatase inhibitors comes into focus

Masters of hematology and oncology: David Alberts, MD

DEPARTMENTS

News & Analysis

Pharmaceutical mergers raise fears of treatment pipeline pruning

Prophylaxis fends off life-threatening invasive fungal infections

MR spectroscopy separates brain tumor recurrence from radiation necrosis

Medicare approves coverage of FDG-PET scans for 11 cancers

Cancer Care: Practice & Policy

Two major studies add fuel to fire of PSA controversy

Focus on Prostate Cancer

Evidence grows for value of high-field MRI in prostate cancer Rx

Most prognostic prostate cancer markers lack clinical utility

Focus on Colon Cancer

Minority groups protest CMS rejection of CT-based colon cancer screening

Focus on Hematology

Clear-cut evidence for routine use of ESA agents remains elusive

Related Videos
Video 4 - "Frontline Treatment for EGFR-Mutated Lung Cancer"
Video 3 - "NGS Testing Challenges and Considerations in NSCLC"
Increasing screening for younger individuals who are at risk of colorectal cancer may help mitigate the rising early incidence of this disease.
Laparoscopy may reduce the degree of pain or length of hospital stay compared with open surgery for patients with colorectal cancer.
Related Content
One of the most important roles of a nurse coordinator is transmitting patient and caregiver information during the CAR T-cell treatment process.

Defining a Nurse Coordinator’s Role During Outpatient CAR T-Cell Therapy

April 26th 2024
Article

One of the most important roles of a nurse coordinator is transmitting patient and caregiver information during the CAR T-cell treatment process.

Richard Lazzaro, MD, discusses how a robot-assisted platform has impacted his thoracic surgery and highlights other potential advancements in the field.

Moving The Needle in Lung Cancer Management With Robotic-Assisted Surgery

April 22nd 2024
Podcast

Richard Lazzaro, MD, discusses how a robot-assisted platform has impacted his thoracic surgery and highlights other potential advancements in the field.

Early inflammatory markers as prognostic indicators following allogeneic stem cell transplantation

Early inflammatory markers as prognostic indicators following allogeneic stem cell transplantation

April 26th 2024
Article

Researchers at the University of Birmingham in the UK have explored the dynamics of inflammatory biomarkers following allogeneic hematopoietic stem cell transplantation.

Experts discuss findings related to gastrointestinal cancer outcomes as well as treatment inequalities presented at the 2024 SSO Annual Meeting.

Surgeons Talk Key Treatment and Institutional Advances Across Oncology Care

April 15th 2024
Podcast

Experts discuss findings related to gastrointestinal cancer outcomes as well as treatment inequalities presented at the 2024 SSO Annual Meeting.

Loncastuximab tesirine and rituximab led to encouraging responses in most patients with relapsed/refractory follicular lymphoma in a single-center study.

Loncastuximab Tesirine Combo Is Effective, Safe in R/R Follicular Lymphoma

April 25th 2024
Article

Loncastuximab tesirine and rituximab led to encouraging responses in most patients with relapsed/refractory follicular lymphoma in a single-center study.

Findings from the CARTITUDE-2 trial support the use of cilta-cel in patients with multiple myeloma, says Tina Glow, AAS, RN, BSN.

Cilta-cel Yields Sustained Responses in R/R Multiple Myeloma

April 25th 2024
Article

Findings from the CARTITUDE-2 trial support the use of cilta-cel in patients with multiple myeloma, says Tina Glow, AAS, RN, BSN.